Working with partners at Lifelabs, Island Health, and the BC Centre on Substance Use, VIU’s Dr. Chris Gill
is combining a paper-based sampling method with the analytical power of mass spectrometry to create
robust tests that can be deployed at harm-reduction sites or as part of a mobile testing service. Our
pioneering efforts with developing paper spray mass spectrometry (PS-MS) for fentanyl harm reduction
have recently been recognized and published in the peer reviewed journal Clinical Biochemistry.
Our brand new, state-of-the-art, mobile mass spectrometry facility, one of only a few in Canada, made its inaugural road trip this fall.